St. Louis will continue to be a major regional laboratory testing center for Quest Diagnostics Incorporated.
As disclosed in the last issue of THE DARK REPORT, rumors from sources deemed credible indicated that all testing now done in St. Louis was to be consolidated at the Chicago laboratory operated by Quest Diagnostics.
“This story is not true,” stated Surya N. Mohapatra, Ph.D., President and Chief Operating Officer at Quest Diagnostics. “We plan to accomplish three basic objectives with our existing resources in St. Louis.
“One, the former SmithKline Beecham Clinical Laboratories (SBCL) St. Louis lab will continue to service its geography,” he explained. “Two, the former SBCL laboratory and the St. Louis joint venture (involving Quest Diagnostics and the Unity Health System) will continue to develop integration plans to consolidate the business units.
SAMHSA Tests To Move
“Three, SAMHSA specimens at the St. Louis joint venture will be moved to the Schaumburg laboratory in Chicago,” noted Dr. Mohapatra. “The SAMHSA license at the St. Louis facility will be allowed to lapse. Currently only about 40 SAMHSA specimens per night are processed by the St. Louis facility.
“St. Louis will continue to be an important market for us,” added Dr. Mohapatra. “We will continue to maintain a strong presence there with a full service laboratory. We are currently finalizing our integration plans to consolidate the two business units we now have there.”
The St. Louis objectives that Quest Diagnostics wants to implement are consistent with the overall integration plans that Quest Diagnostics established after its acquisition of SBCL last summer. Quest Diagnostics must meld two separate national laboratory systems into one organization, with a common corporate culture and a uniform level of client service.
The above information, provided by Dr. Mohapatra, corrects rumors that were included in Intelligence Late and Latent in the February 14, 2000 issue of THE DARK REPORT. We are committed to a high standard of accuracy in the information presented to our clients. As the lab industry’s leading and most respected source for accurate and useful business intelligence, we believe it is important to correct any information we may believe to be true, but is later demonstrated to be inaccurate or misleading—Editor.